Multiple primary malignant tumors in patients with head and neck cancer: Results of a prospective study and future perspectives

被引:102
作者
Dhooge, IJ
De Vos, M
Van Cauwenberge, PB
机构
[1] State Univ Ghent Hosp, Dept Otolaryngol, B-9000 Ghent, Belgium
[2] State Univ Ghent Hosp, Dept Gastroenterol, B-9000 Ghent, Belgium
关键词
D O I
10.1097/00005537-199802000-00017
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Multiple primary tumors are a known phenomenon in head and neck cancer, They are partially responsible for the limited improvement in survival of head and neck cancer during the past 20 years. Only a few prospective data have been published about the incidence of metachronous tumors, The authors prospectively studied 127-patients with squamous cell carcinoma of the head and neck, The overall incidence of second primary tumors was 13.5% (simultaneously, 3%; synchronously, 5.5%; and metachronously, 8%). More than 90% of the recurrences of the first primary tumor occurred within the first 2 years following primary treatment, but the second primary tumors continued to occur gradually in the course of follow-up, Most of the second primary tumors were discovered because the patients developed symptoms (14/17). Survival after detection of the second primary tumor was poor, The development of a second primary tumor was of equivalent prognosis to a recurrence of the primary tumor. Future directives include the development of more adequate screening methods, Identification of potential early markers for the development of a squamous cell carcinoma at the level of the mucosa at risk and in serum could be of value for the early detection of individuals at risk.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 45 条
[1]
ATKINS JP, 1984, ARCH OTOLARYNGOL, V110, P533
[2]
TRIPLE ENDOSCOPY - A VALUABLE PROCEDURE IN HEAD AND NECK-SURGERY [J].
ATKINSON, D ;
FLEMING, S ;
WEAVER, A .
AMERICAN JOURNAL OF SURGERY, 1982, 144 (04) :416-419
[3]
Bongers V, 1996, J PATHOL, V178, P284
[5]
CHOY ATK, 1992, CANCER, V70, P815, DOI 10.1002/1097-0142(19920815)70:4<815::AID-CNCR2820700416>3.0.CO
[6]
2-Q
[7]
Cohn A M, 1980, Am J Otolaryngol, V1, P411, DOI 10.1016/S0196-0709(80)80022-6
[8]
COPPER MP, 1995, ARCH OTOLARYNGOL, V121, P157
[9]
DAY GL, 1994, J NATL CANCER I, V86, P1331
[10]
THE EUROSCAN STUDY [J].
DEVRIES, N ;
VANZANDWIJK, N ;
PASTORINO, U .
BRITISH JOURNAL OF CANCER, 1991, 64 (06) :985-989